VistaGen Therapeutics (VTGN) Financials

VistaGen Therapeutics Inc (VTGN) is a biopharmaceutical company that focuses on developing innovative medicines for mental health disorders. The company's financial performance can be analyzed through its income statement, balance sheet, and cash flow statement. The income statement provides information on the company's revenue, expenses, and net income. For VTGN, the total revenue for the latest fiscal year was $X million, with the gross profit amounting to $X million. The net income from stockholders was $X million.

The balance sheet of VTGN reveals the company's financial position at a specific point in time. It includes information on assets, liabilities, and stockholders' equity. As of the latest reporting period, VTGN reported total assets of $X million. The total liabilities amounted to $X million, with stockholders' equity at $X million. In terms of liquidity, VTGN had cash equivalents of $X million.

VTGN's cash flow statement provides insights into the company's cash inflows and outflows. It is divided into three sections: operating activities, investing activities, and financing activities. Operating cash flow for VTGN was $X million, reflecting the cash generated from its core business operations. Investing cash flow, which includes capital expenditures and acquisitions, was $X million. Financing cash flow, which involves activities such as debt issuance and stock repurchases, amounted to $X million. VTGN's free cash flow, which represents the cash available after capital expenditures, was $X million.

An important financial metric for VTGN is EBIT (earnings before interest and taxes). This measure provides insights into a company's operating profitability. EBITDA (earnings before interest, taxes, depreciation, and amortization) is another important metric that factors in non-cash expenses. VTGN's EBIT for the latest fiscal year was $X million, while EBITDA amounted to $X million.

In terms of debt, VTGN reported a net debt of $X million. This represents the company's total debt minus its cash and cash equivalents. It is a measure of VTGN's ability to fulfill its financial obligations. The company's total debt was $X million, and its total liability, including both short-term and long-term liabilities, was $X million.

In summary, VTGN's financials highlight the company's revenue, profitability, liquidity, and debt position. These metrics provide investors and stakeholders with a comprehensive view of VTGN's financial performance and help assess its financial health.